Evaluation of the Metricath Gemini System, a Device Intended to Make Arterial Measurements and Perform Angioplasty Dilations.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Kandzari, MD
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, USA
Principal Investigator - Evelyn Regar, MD
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, The Netherlands
Principal Investigator - Willem van der Giessen, MD
Department of Cardiology, Thoraxcenter, Erasmus Medical Center, The Netherlands
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Paul'S Hospital
Vancouver, British Columbia, Canada
- Vancouver Hospital
Vancouver, British Columbia, Canada
- Amphia Hospital
Breda, The Netherlands, Netherlands
- Leiden University Medical Center
Leiden, The Netherlands, Netherlands
- Medisch Centrum Rijmond Zuid
Rotterdam, The Netherlands, Netherlands
- University Medical Center Rotterdam
Rotterdam, The Netherlands, Netherlands
- Uc Irvine Medical Center
Orange, California, United States
- Mercy Heart Institute
Sacramento, California, United States
- Pasco Cardiology Center
Hudson, Florida, United States
- Baptist Miami Hospital
Miami, Florida, United States
- Florida Cardiovascular Institute
Tampa, Florida, United States
- Sinai Hospital
Baltimore, Maryland, United States
- Columbia Presbyterian Hospital
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Oklahoma
Oklahoma City, Oklahoma, United States
- Tyler Cardiovascular Consultants
Tyler, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2005
- Primary completion
- 30 Nov 2007
- Completion
- 31 Mar 2009
- Last update posted
- 13 May 2009
- Registered enrollment
- 145
- Registry id
- NCT00399646
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.